There are 200 million people in the world living with age-related macular degeneration (AMD), and in approximately a fifth of these cases, the disease progresses to an advanced stage, leading to visual impairment. Advanced AMD is divided into wet and dry forms. While wet AMD can be treated with medical injections, approximately four fifths of advanced AMD cases are of the dry form, for which there is currently no medical treatment.
* This article was originally published here
